Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Infectious diseases

Integrating vaccines and monoclonal antibodies into malaria prevention

Nature Medicine volume 30, pages 37–38 (2024)Cite this article

Two malaria vaccines are approved and several prophylactic antibodies are in development, but a combination of strategies tailored to different epidemiological situations will be needed if malaria is to be eliminated.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The malaria life cycle and targets for monoclonal antibodies.

References

  1. World Health Organization. WHO Guidelines for Malaria 2023 https://go.nature.com/48zjClh (2023).

  2. Nussenzweig, R. et al. Mil. Med. 134, 1176–1182 (1969).

    Article  CAS  PubMed  Google Scholar 

  3. Clyde, D. F. et al. Am. J. Med. Sci. 266, 169–177 (1973).

    Article  CAS  PubMed  Google Scholar 

  4. Gaudinski, M. R. et al. N. Engl. J. Med. 385, 803–814 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wu, R. L. et al. N. Engl. J. Med. 387, 397–407 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kayentao, K. et al. N. Engl. J. Med. 377, 1833–1842 (2022).

    Article  Google Scholar 

  7. Williams, K. L. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02659-z (2024).

    Article  PubMed  Google Scholar 

  8. Regules, J. A. et al. J. Infect. Dis. 214, 732–772 (2016).

    Article  Google Scholar 

  9. World Health Organization. World Malaria Report 2023 https://go.nature.com/48ummR6 (2023).

  10. Kapulu, M. C. et al. JCI Insight 6, e146443 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  11. World Health Organizaton. Monoclonal Antibodies for Malaria Prevention https://go.nature.com/3RLKwj0 (2023).

  12. Stanisic, D. I. et al. BioDrugs 37, 737–756 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA

    Terrie E. Taylor

  2. Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi

    Terrie E. Taylor

  3. Department of Life Sciences, Imperial College London, London, UK

    Faith Osier

Authors
  1. Terrie E. Taylor
    View author publications

    Search author on:PubMed Google Scholar

  2. Faith Osier
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Terrie E. Taylor.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, T.E., Osier, F. Integrating vaccines and monoclonal antibodies into malaria prevention. Nat Med 30, 37–38 (2024). https://doi.org/10.1038/s41591-023-02745-2

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41591-023-02745-2

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing